16.3 |
65.3 |
GO:0090579 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
15.8 |
47.3 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
13.6 |
40.9 |
GO:1900195 |
spindle assembly involved in female meiosis I(GO:0007057) positive regulation of oocyte maturation(GO:1900195) |
11.1 |
44.5 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
10.8 |
43.1 |
GO:0046035 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
10.1 |
30.4 |
GO:1990022 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
8.5 |
76.4 |
GO:0043570 |
maintenance of DNA repeat elements(GO:0043570) |
8.1 |
80.9 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
6.7 |
93.4 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
6.1 |
49.1 |
GO:0060699 |
regulation of endoribonuclease activity(GO:0060699) |
5.5 |
27.4 |
GO:0090306 |
spindle assembly involved in meiosis(GO:0090306) |
5.5 |
54.8 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
5.4 |
32.4 |
GO:0019060 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
5.3 |
32.1 |
GO:2000825 |
positive regulation of androgen receptor activity(GO:2000825) |
5.0 |
29.8 |
GO:0019249 |
lactate biosynthetic process(GO:0019249) |
4.9 |
44.5 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
4.7 |
37.6 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
4.6 |
18.4 |
GO:0019747 |
regulation of isoprenoid metabolic process(GO:0019747) |
4.5 |
13.4 |
GO:0014016 |
neuroblast differentiation(GO:0014016) |
4.4 |
8.9 |
GO:0044211 |
CTP salvage(GO:0044211) |
4.4 |
8.8 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
4.3 |
51.9 |
GO:0015074 |
DNA integration(GO:0015074) |
4.3 |
12.8 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
4.0 |
11.9 |
GO:1901535 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) regulation of genetic imprinting(GO:2000653) |
3.9 |
11.7 |
GO:2001245 |
regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
3.9 |
7.7 |
GO:0097695 |
establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) |
3.8 |
34.1 |
GO:0030091 |
protein repair(GO:0030091) |
3.7 |
11.2 |
GO:0036333 |
hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
3.7 |
63.5 |
GO:0090129 |
positive regulation of synapse maturation(GO:0090129) |
3.5 |
56.5 |
GO:0000338 |
protein deneddylation(GO:0000338) |
3.5 |
65.8 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) |
3.3 |
90.2 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
3.3 |
13.1 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
3.2 |
9.6 |
GO:0044209 |
AMP salvage(GO:0044209) |
3.2 |
373.7 |
GO:0000079 |
regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
3.2 |
15.8 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
3.0 |
12.2 |
GO:0043981 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
3.0 |
14.8 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
2.9 |
11.6 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
2.9 |
8.6 |
GO:1904751 |
positive regulation of protein localization to nucleolus(GO:1904751) |
2.7 |
21.7 |
GO:0015866 |
ADP transport(GO:0015866) |
2.7 |
16.2 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
2.7 |
24.0 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
2.5 |
27.8 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
2.5 |
4.9 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
2.5 |
12.3 |
GO:0090649 |
response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
2.5 |
12.3 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
2.4 |
94.6 |
GO:2000816 |
negative regulation of mitotic sister chromatid separation(GO:2000816) |
2.1 |
34.3 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
2.1 |
31.9 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
2.1 |
6.3 |
GO:0060152 |
peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
2.1 |
6.2 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
2.1 |
20.7 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
2.0 |
6.0 |
GO:0071048 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
2.0 |
6.0 |
GO:0006425 |
glutaminyl-tRNA aminoacylation(GO:0006425) |
2.0 |
13.8 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
1.9 |
13.5 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
1.9 |
7.6 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
1.9 |
17.0 |
GO:0006089 |
lactate metabolic process(GO:0006089) |
1.9 |
7.5 |
GO:0021564 |
vagus nerve development(GO:0021564) |
1.9 |
97.0 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
1.9 |
5.6 |
GO:0019482 |
purine nucleobase catabolic process(GO:0006145) beta-alanine metabolic process(GO:0019482) |
1.9 |
46.4 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
1.8 |
7.4 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
1.8 |
35.0 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
1.8 |
7.3 |
GO:0046833 |
positive regulation of RNA export from nucleus(GO:0046833) |
1.8 |
38.3 |
GO:0046931 |
pore complex assembly(GO:0046931) |
1.8 |
32.6 |
GO:1990001 |
inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
1.8 |
23.4 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
1.8 |
14.4 |
GO:1900004 |
negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
1.7 |
27.7 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
1.7 |
15.3 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
1.7 |
5.0 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
1.7 |
8.3 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
1.7 |
13.3 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
1.6 |
3.2 |
GO:1903423 |
positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
1.6 |
11.1 |
GO:0031118 |
rRNA pseudouridine synthesis(GO:0031118) |
1.6 |
44.1 |
GO:0061641 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
1.6 |
9.4 |
GO:1903756 |
regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
1.6 |
17.2 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
1.5 |
4.6 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
1.5 |
21.4 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
1.5 |
22.4 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
1.5 |
7.4 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.4 |
24.2 |
GO:0032802 |
low-density lipoprotein particle receptor catabolic process(GO:0032802) |
1.4 |
21.1 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
1.4 |
2.8 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
1.4 |
30.2 |
GO:0048255 |
mRNA stabilization(GO:0048255) |
1.3 |
4.0 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
1.3 |
6.4 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
1.3 |
6.4 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
1.3 |
7.6 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) positive regulation of autophagosome maturation(GO:1901098) |
1.3 |
7.6 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
1.3 |
8.8 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
1.2 |
7.5 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
1.2 |
3.6 |
GO:0061357 |
positive regulation of Wnt protein secretion(GO:0061357) |
1.2 |
10.6 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
1.2 |
4.7 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
1.2 |
13.9 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
1.1 |
5.5 |
GO:0052199 |
negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) negative regulation by host of symbiont molecular function(GO:0052405) |
1.1 |
3.2 |
GO:0046010 |
positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
1.1 |
6.4 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
1.1 |
5.3 |
GO:0061767 |
negative regulation of lung blood pressure(GO:0061767) |
1.0 |
15.7 |
GO:0016024 |
CDP-diacylglycerol biosynthetic process(GO:0016024) |
1.0 |
5.1 |
GO:0070980 |
biphenyl catabolic process(GO:0070980) |
1.0 |
13.0 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
1.0 |
3.0 |
GO:0060437 |
lung growth(GO:0060437) |
1.0 |
7.9 |
GO:0019695 |
choline metabolic process(GO:0019695) |
1.0 |
95.1 |
GO:0006521 |
regulation of cellular amino acid metabolic process(GO:0006521) |
0.9 |
2.8 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
0.9 |
36.5 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
0.9 |
3.7 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.9 |
3.6 |
GO:1903436 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.9 |
16.9 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.9 |
19.3 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.9 |
5.3 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
0.9 |
8.7 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
0.8 |
9.8 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
0.8 |
18.8 |
GO:0072663 |
protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.8 |
22.1 |
GO:0003094 |
glomerular filtration(GO:0003094) |
0.8 |
5.6 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
0.8 |
8.7 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.8 |
15.5 |
GO:0006465 |
signal peptide processing(GO:0006465) |
0.8 |
5.4 |
GO:0048511 |
rhythmic process(GO:0048511) |
0.8 |
6.1 |
GO:0010624 |
regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.8 |
6.8 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.7 |
6.4 |
GO:0070900 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.7 |
2.1 |
GO:1904578 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
0.7 |
2.1 |
GO:0051919 |
positive regulation of fibrinolysis(GO:0051919) |
0.7 |
25.9 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
0.7 |
3.5 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.7 |
50.0 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) mitochondrial translational termination(GO:0070126) |
0.7 |
29.4 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
0.7 |
10.9 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
0.7 |
6.1 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
0.7 |
4.0 |
GO:1903435 |
positive regulation of constitutive secretory pathway(GO:1903435) |
0.7 |
5.3 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
0.6 |
2.5 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
0.6 |
12.6 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
0.6 |
12.9 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.6 |
9.2 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.6 |
21.6 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
0.6 |
21.8 |
GO:1902475 |
neutral amino acid transport(GO:0015804) L-alpha-amino acid transmembrane transport(GO:1902475) |
0.6 |
1.1 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
0.5 |
8.1 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
0.5 |
4.2 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
0.5 |
14.3 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
0.5 |
13.3 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
0.5 |
4.9 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
0.5 |
1.9 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
0.5 |
26.8 |
GO:0043392 |
negative regulation of DNA binding(GO:0043392) |
0.5 |
2.7 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
0.4 |
0.9 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
0.4 |
2.2 |
GO:0006581 |
acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
0.4 |
1.8 |
GO:0046725 |
negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of nephron tubule epithelial cell differentiation(GO:0072183) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) negative regulation of epithelial cell differentiation involved in kidney development(GO:2000697) |
0.4 |
5.2 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.4 |
1.7 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
0.4 |
6.3 |
GO:0042100 |
B cell proliferation(GO:0042100) |
0.4 |
2.9 |
GO:0008218 |
bioluminescence(GO:0008218) |
0.4 |
1.2 |
GO:0070233 |
regulation of T cell apoptotic process(GO:0070232) negative regulation of T cell apoptotic process(GO:0070233) regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 |
4.1 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
0.4 |
25.5 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
0.4 |
1.9 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.4 |
6.2 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
0.4 |
12.5 |
GO:0002026 |
regulation of the force of heart contraction(GO:0002026) |
0.4 |
4.1 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
0.4 |
2.6 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.4 |
2.6 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
0.4 |
3.7 |
GO:0015781 |
pyrimidine nucleotide-sugar transport(GO:0015781) |
0.4 |
5.1 |
GO:0006293 |
nucleotide-excision repair, preincision complex stabilization(GO:0006293) nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.4 |
16.5 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
0.4 |
1.4 |
GO:0090206 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.3 |
4.4 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
0.3 |
6.2 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
0.3 |
12.2 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
0.3 |
1.6 |
GO:1901906 |
diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.3 |
20.2 |
GO:0001895 |
retina homeostasis(GO:0001895) |
0.3 |
1.1 |
GO:0010454 |
negative regulation of cell fate commitment(GO:0010454) mammary gland bud morphogenesis(GO:0060648) regulation of determination of dorsal identity(GO:2000015) |
0.3 |
10.6 |
GO:0015949 |
nucleobase-containing small molecule interconversion(GO:0015949) |
0.3 |
8.1 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
0.3 |
16.2 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 |
15.9 |
GO:0051225 |
spindle assembly(GO:0051225) |
0.2 |
10.0 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
0.2 |
4.2 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
0.2 |
14.1 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
0.2 |
14.1 |
GO:1901222 |
regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.2 |
3.5 |
GO:0006309 |
apoptotic DNA fragmentation(GO:0006309) |
0.2 |
11.5 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
0.2 |
9.6 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
0.2 |
3.6 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 |
9.4 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 |
7.8 |
GO:0071377 |
cellular response to glucagon stimulus(GO:0071377) |
0.2 |
5.7 |
GO:0016071 |
mRNA metabolic process(GO:0016071) |
0.2 |
5.3 |
GO:0006298 |
mismatch repair(GO:0006298) |
0.2 |
0.9 |
GO:0002002 |
regulation of angiotensin levels in blood(GO:0002002) angiotensin maturation(GO:0002003) regulation of angiotensin metabolic process(GO:0060177) |
0.2 |
4.8 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
0.1 |
2.4 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
0.1 |
1.0 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
0.1 |
2.2 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
0.1 |
1.9 |
GO:0045116 |
protein neddylation(GO:0045116) |
0.1 |
2.8 |
GO:0010801 |
negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 |
0.9 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
0.1 |
9.7 |
GO:0035722 |
interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
0.1 |
1.3 |
GO:0017145 |
stem cell division(GO:0017145) |
0.1 |
2.6 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
0.1 |
8.3 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 |
2.3 |
GO:0045577 |
regulation of B cell differentiation(GO:0045577) |
0.1 |
11.0 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
0.1 |
4.2 |
GO:0035987 |
endodermal cell differentiation(GO:0035987) |
0.1 |
3.2 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
0.1 |
1.5 |
GO:0046628 |
positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.1 |
3.2 |
GO:0006333 |
chromatin assembly or disassembly(GO:0006333) |
0.1 |
1.8 |
GO:0006144 |
purine nucleobase metabolic process(GO:0006144) |
0.1 |
0.7 |
GO:0007566 |
embryo implantation(GO:0007566) |
0.1 |
0.6 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
0.1 |
0.6 |
GO:0045905 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 |
1.4 |
GO:0001502 |
cartilage condensation(GO:0001502) |
0.1 |
8.6 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 |
3.9 |
GO:0048024 |
regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.1 |
3.0 |
GO:0000245 |
spliceosomal complex assembly(GO:0000245) |
0.1 |
1.1 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
0.1 |
8.3 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
0.1 |
0.3 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
0.0 |
1.4 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
0.0 |
2.1 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
0.0 |
7.6 |
GO:0070585 |
protein localization to mitochondrion(GO:0070585) |
0.0 |
1.0 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
0.0 |
2.5 |
GO:0006446 |
regulation of translational initiation(GO:0006446) |
0.0 |
0.5 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 |
0.6 |
GO:0006695 |
cholesterol biosynthetic process(GO:0006695) |
0.0 |
0.5 |
GO:0051028 |
mRNA transport(GO:0051028) |
0.0 |
0.9 |
GO:1904837 |
beta-catenin-TCF complex assembly(GO:1904837) |
0.0 |
0.7 |
GO:0006491 |
N-glycan processing(GO:0006491) |
0.0 |
0.3 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 |
0.1 |
GO:0035801 |
adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) visceral serous pericardium development(GO:0061032) posterior mesonephric tubule development(GO:0072166) negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
0.0 |
0.6 |
GO:0007050 |
cell cycle arrest(GO:0007050) |
0.0 |
0.4 |
GO:0051353 |
positive regulation of oxidoreductase activity(GO:0051353) |
0.0 |
2.2 |
GO:0002576 |
platelet degranulation(GO:0002576) |